PATENT CLAIM ANALYSIS

Application Number: 16002441
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "575000"]

Abstract:
The present invention includes compositions for treating cancer, and methods using same. In certain embodiments, the compositions of the invention comprise a histone deacetylase inhibitor (HDACi), a cyclodextrin, water, optionally a polyalkylene glycol, and optionally dimethyl sulfoxide (DMSO). In other embodiments, the compositions of the invention comprise a HDACi, a cyclodextrin, water, a polyalkylene glycol, and DMSO.

Claim (Index 7):
The method of  claim 1 , wherein the composition comprises a cyclodextrin concentration selected from the group consisting of: about 200 mg/mL; about 180 mg/mL; about 160 mg/mL; about 140 mg/mL; about 120 mg/mL; about 100 mg/mL; about 90 mg/mL; about 80 mg/mL; about 70 mg/mL; about 60 mg/mL; about 50 mg/mL; about 40 mg/mL; about 30 mg/mL; about 25 mg/mL; about 20 mg/mL; about 15 mg/mL; about 12.5 mg/mL; about 10 mg/mL; about 8 mg/mL; about 6.5 mg/mL; about 6 mg/mL; about 5 mg/mL; about 4 mg/mL; about 3 mg/mL; about 2.5 mg/mL; about 2 mg/mL; and about 1 mg/mL.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 94.0
- Lexical Diversity: 2.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14737473', '15813582', '14451928', '15128977', '15998610']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.777028161356076
- 35 USC 102 Novelty (BERT): 0.5110981974105279
- Combined Prediction Score: 0.7504351649615212
- Mean Citation Score: 214.736758
- Max Citation Score: 246.10732
- Similarity Product: 147.2401223492169

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test